Reddy's gets DCGI nod for Zytorvi in cancer

🇮🇳 Economic Times India (IN) —
Reddy's gets DCGI nod for Zytorvi in cancer

AI Summary

Dr. Reddy’s Laboratories received approval from India’s drug regulator, the DCGI, for Zytorvi, a cancer treatment. The headline does not provide details on the indication, launch timing, or commercial prospects.

Markets Health Dr. Reddy's Laboratories DCGI approval Zytorvi cancer treatment India

Read original source →